Combined therapy for migraine prevention? Clinical experience with a β-blocker plus sodium valproate in 52 resistant migraine patients

Cephalalgia

Volumn 23, Issue 10, 2003, Pages 961-962

  Pascual, J ^a   Leira, R ^b   Lainez J M ^c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Migraine; Migraine prevention; Nadolol; Propranolol; Sodium valproate

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL; PROPRANOLOL; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MONOTHERAPY; SIDE EFFECT; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; VALPROIC ACID;

EID: 0346958580     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00615.x     Document Type: Article

References (4)

1. Tfelt-Hansen P, Welch KMA. Prioritizing prophylactic treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 2000:499-500.
2. Tfelt-Hansen P, Welch KMA. General principles of pharmacological treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 2000:385-90.
3. Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff's headache and other head pain. Oxford: Oxford University Press, 2001:121-237.
4. Van der Kuy PHM, Lohman JJHM. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002; 22:265-70.